Energy density testing of the Gelion (LON: GELN) lithium-sulphur battery technology shows that it far exceeds lithium-ion batteries. The 9.5 Ah pouch cell achieved an energy density of 395 Wh/kg, which 60% higher than lithium-ion batteries. This means that the batteries could be lighter and cheaper and made from more abundant materials, but there is […]

The post AIM movers: Gelion testing success and ex-dividends appeared first on UK Investor Magazine.

Roadside Real Estate (LON: ROAD) shares have soared 172.3% to 8.85p – the highest level for six months – after it sold part of its stake in Cambridge Sleep Sciences to CGV Ventures 1 for £6m. The total stake cost £2.7m and Roadside Real Estate still owns 65%, having sold a 10% stake, so it […]

The post AIM movers: Roadside Real Estate non-core gain and Naked Wines cash improves appeared first on UK Investor Magazine.

Sulforaphane-based medicines developer Evgen Pharma (LON: EVG) has issued a notice of dispute with Stalicla its partner in autism spectrum disorder and other neurodevelopmental disorders. The share price has fallen by more than one-quarter to 1.1p, which is a new all-time low. AIM-quoted Evgen Pharma licenced the global rights for SFX-01 in neurodevelopmental disorders and […]

The post Evgen Pharma in dispute with partner appeared first on UK Investor Magazine.

Francisco Partners II is making a recommended cash offer for e-waste and data erasure company Blancco Technology Group (LON: BLTG). The bid is 223p/share and the share price jumped 22.4% to 219p. The share price has not been as high as the bid for 18 months. Blancco management believe the help of a backer with […]

The post AIM movers: Blancco Technology bid and Deltex Medical slumps on return from suspension appeared first on UK Investor Magazine.

The Microsaic Systems (LON: MSYS) share price has recovered 60% to 0.012p, although it has still nearly halved this week. The scientific instruments company needs more cash because of the £1.35m in overdue payments from DeepVerge (LON: DVRG) and a slow start to the year. Microsaic Systems assumes no more payments from DeepVerge, which is […]

The post AIM Movers: Microsaic Systems recovers and Physiomics falls to just above placing price appeared first on UK Investor Magazine.

Jersey Oil & Gas (LON: JOG) has received approval for the Greater Buchan Area farm-out to NEO Energyfrom the regulator and the deal should be completed by the end of the month. An extension has been granted to the Buchan licence to enable a field development plan to be compiled. The share price is 3.9% […]

The post AIM movers: Jersey Oil & Gas farm-out approved and IOG gas flow problem appeared first on UK Investor Magazine.

Pathfinder Minerals (LON: PFP) has signed a conditional sale and purchase agreement with Acumen Advisory for the disposal of IM Minerals. This was originally announced earlier this year and the deal includes claims against the Mozambique government. The deal requires shareholder approval. There is an initial £2m payment and a contingent payment of the higher […]

The post AIM movers: Pathfinder Minerals finalises disposal and Anpario profit slump appeared first on UK Investor Magazine.

Digital mental health company Kooth (LON: KOO) has won a significant contract in California covering 13-25 year olds. Services will be provided to the Behavioural Health Virtual Services Platform, and they will launch in January 2024. Specific terms are still to be finalised, but there should be a material impact on annualised recurring revenues from […]

The post AIM movers: California contract for Kooth and ex-dividends appeared first on UK Investor Magazine.

It has been a good week for drug developer Evgen (LON: EVG), which is partnering with Swiss biotech Stalicia for the potential use of SFX-01 for the treatment of autism spectrum disorder and other CNS disorders. This deal could generate up to $160.5m in milestone payments and double-digit royalties, although that is a long way […]

The post AIM weekly movers: Evgen has a good week appeared first on UK Investor Magazine.

Drug modelling consultancy Physiomics (LON: PYC) has announced a collaboration with Cancer Research UK, which will use the company’s modelling technology for early phase clinical development of ALETA-001. This is a CAR-T cell engager blood cancer treatment candidate. This modelling should be completed by the end of 2022. This follows the recent dose selection contract […]

The post AIM movers: Physiomics contract and DeepVerge cash requirement appeared first on UK Investor Magazine.

Energy and water efficiency equipment provider Eneraqua Technologies (LON: ETP) grew its interims from a combination of organic growth and a contribution from recent acquisition Welltherm, which provides drilling services for heat pump installation. Revenues were 92% higher at £24.2m, while underlying pre-tax profit was £3m. Full year expectations are covered by contracted orders as […]

The post AIM movers: Eneraqua energy growth and coal production recommences at Edenville Energy appeared first on UK Investor Magazine.

Drug developer Evgen (LON: EVG) is partnering with Swiss biotech Stalicia for the potential use of SFX-01 for the treatment of autism spectrum disorder and other CNS disorders. The share price jumped 63.2% to 4.65p. This deal could generate up to $160.5m in milestone payments and double-digit royalties, although that is a long way away. […]

The post AIM movers: Evgen drug deal and no oil at Serenity for Europa and i3 Energy appeared first on UK Investor Magazine.